Gradient Investments LLC Biogen Inc. Transaction History

Gradient Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$187.54 - $223.02 $375 - $446	-2 Reduced 0.86%	230 $47,000
Q1 2021 Apr 21, 2021	SELL	$242.95 - $284.63 $728 - $853	-3 Reduced 1.28%	232 $65,000
Q3 2020 Oct 06, 2020	BUY	$264.77 - $305.71 $794 - $917	3 Added 1.29%	235 $67,000
Q2 2020 Jul 10, 2020	SELL	$258.66 - $342.55 $2,069 - $2,740	-8 Reduced 3.33%	232 $62,000
Q1 2020 Apr 07, 2020	SELL	$268.85 - $341.04 $1,613 - $2,046	-6 Reduced 2.44%	240 $76,000
Q4 2019 Jan 15, 2020	SELL	$220.06 - $304.07 $880 - $1,216	-4 Reduced 1.6%	246 $73,000
Q3 2019 Oct 10, 2019	BUY	$217.44 - $243.88 $4,348 - $4,877	20 Added 8.7%	250 $58,000
Q4 2018 Jan 18, 2019	SELL	$278.5 - $352.75 $1,114 - $1,411	-4 Reduced 1.71%	230 $69,000
Q4 2017 Feb 07, 2018	BUY	$307.64 - $344.58 $71,987 - $80,631	234	234 $75,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.